INNOVATIVE CONCEPTS IN DRUG DEVELOPMENT
Registration number 498607449 · France
INNOVATIVE CONCEPTS IN DRUG DEVELOPMENT is a dissolved Simplified joint-stock company (SAS) registered in France, incorporated in 2015 (about 11 years ago), dissolved in 2022. It has share capital of €150k. It has 1 director / officer on record and 3 shareholders. A court ordered its judicial liquidation in 2022.
- Jurisdiction
- France
- Incorporated
- 2015-02-27
- Dissolved
- 2022-07-28
- Share capital
- €149,525
- Type
- 5710
- Registered address
- 800 AV DU CHATEAU DE JOUQUES, 13420 GEMENOS
- Post code
- 13420
- Registry
- INPI
- Status
- Dissolved
Insolvency proceedings
Official public record — BODACC (Bulletin Officiel des Annonces Civiles et Commerciales).
- Closure of proceedings · 2022-07-27 Greffe du Tribunal de Commerce de Marseille
- Insolvency event · 2021-02-22 TRIBUNAL DE COMMERCE DE MARSEILLE
- Court-supervised reorganisation · 2020-06-04 TRIBUNAL DE COMMERCE DE MARSEILLE
- Judicial liquidation · 2019-06-06 TRIBUNAL DE COMMERCE DE MARSEILLE
- Court-supervised reorganisation · 2019-01-10 TRIBUNAL DE COMMERCE DE MARSEILLE
Directors & officers
- NATHALIE COMPAGNONE Président du conseil d'administration
Shareholders / founders
- 🧑 ANDREE CANOVAS
- 🧑 GILLES ROCHE
- 🧑 XAVIER CHENIVESSE
Companies at the same registered address
- COFRADIS SUD COMPAG FRANCAISE DISTRI SUD
- CENTRALE EUROPEENNE INFORMATION PUBLICIT
- ESEN
- A.C.S.E.
- CLAUDE CAMILLE ANDRE GALANT
- ECONERGIES
Check reliability score & connections →
Full KYB reliability score, EU/OFAC/UK/US sanctions screening and the ownership graph are in the app and the API.